The inhibition of T cell proliferation in a mixed lymphocyte reaction by Itolizumab (T1h) is associated with reduction in pro inflammatory cytokines and CD6 internalization. (52.27)
J Immunol (2011) 186 (1_Supplement): 52.27.
Currently there are no citedby results. Try again later.
